Skip to content

Clinical trials

Phase 2 Sepsis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Phase: Phase 2 Clear all

144 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20043
20054
20064
20077
20087
20092
20107
20112
20127
20133
20144
20151
20166
20175
20188
20199
20209
202110
20229
20237
202411
20252
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76
Unknown status23
Recruiting13
Terminated12
Withdrawn11
Not yet recruiting6
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dascena5
M.D. Anderson Cancer Center5
University of Roma La Sapienza5
AstraZeneca4
Hellenic Institute for the Study of Sepsis4
AM-Pharma3
Beth Israel Deaconess Medical Center3
ImmunityBio, Inc.3
Mansoura University3
Ottawa Hospital Research Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis144
Shock, Septic52
Infections11
Respiratory Distress Syndrome10
Critical Illness8
Shock7
Acute Kidney Injury6
Systemic Inflammatory Response Syndrome6
Acute Lung Injury5
Multiple Organ Failure5

Trials

Showing 26 to 50 of 144. Each trial links to its page on Pharma Observatory.

44 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.